Page last updated: 2024-09-03

y 27632 and Experimental Hepatoma

y 27632 has been researched along with Experimental Hepatoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arihiro, K; Asahara, T; Fudaba, Y; Kobayashi, T; Miyata, Y; Ogawa, T; Okajima, M; Tashiro, H; Ushitora, Y1
Chen, XS; Han, LZ; Li, QG; Qiu, F; Xi, ZF; Xia, Q; Xue, F; Zhang, JJ; Zhang, M1

Other Studies

2 other study(ies) available for y 27632 and Experimental Hepatoma

ArticleYear
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:2

    Topics: Amides; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Liver Neoplasms, Experimental; Liver Transplantation; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred BUF; rho-Associated Kinases; Signal Transduction; Tacrolimus

2007
Rho signaling inhibitor, Y-27632, inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model.
    Chinese medical journal, 2007, Dec-20, Volume: 120, Issue:24

    Topics: Actins; Amides; Animals; Apoptosis; Cytoskeleton; Enzyme Inhibitors; Female; Liver Neoplasms, Experimental; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Pyridines; ras Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; rhoC GTP-Binding Protein

2007